Evidence map›Paper›PMID 29887922›Full record

ReviewEuropean geriatric medicine2018

Vaccination programs for older adults in an era of demographic change.

T Mark Doherty, Mark P Connolly, Giuseppe Del Giudice, Johan Flamaing, Jorg J Goronzy, Beatrix Grubeck-Loebenstein, Paul-Henri Lambert, Stefania Maggi, Janet E McElhaney, Hideaki Nagai and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in European geriatric medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Vaccinations for older adults.Bulletin of the World Health Organization · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Clinical inertia in elderly for vaccination.Journal of family medicine and primary care · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 8 countries.

T Mark DohertyGSK, Wavre, Belgium. mark.x.doherty@gsk.com.ORCID http://orcid.org/0000-0003-3009-7969
Mark P ConnollyGlobal Market Access Solutions, St-Prex, Switzerland.
Giuseppe Del GiudiceGSK, Siena, Italy.
Johan FlamaingDepartment of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium.
Jorg J GoronzyDivision of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, USA.
Beatrix Grubeck-LoebensteinInstitute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria.
Paul-Henri LambertCenter of Vaccinology, University of Geneva, Geneva, Switzerland.
Stefania MaggiCNR Institute of Neuroscience, Aging Branch, Padua, Italy.
Janet E McElhaneyHealth Sciences North Research Institute, Sudbury, ON, Canada.
Hideaki NagaiCenter for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
William SchaffnerVanderbilt University School of Medicine, Nashville, TN, USA.
Ruprecht Schmidt-OttGSK, Wavre, Belgium.
Edward WalshDepartment of Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
Alberta Di PasqualeGSK, Wavre, Belgium.
GlaxoSmithKline (Belgium) · BEHealth Sciences North · CAKU Leuven · BENeuroscience Institute · ITStanford University · USTokyo National Hospital · JPUniversität Innsbruck · ATUniversity of Geneva · CHUniversity of Groningen · NLUniversity of Rochester · USVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPopulations are aging worldwide. This paper summarizes some of the challenges and opportunities due to the increasing burden of infectious diseases in an aging population.

resultsOlder adults typically suffer elevated morbidity from infectious disease, leading to increased demand for healthcare resources and higher healthcare costs. Preventive medicine, including vaccination can potentially play a major role in preserving the health and independence of older adults. However, this potential of widespread vaccination is rarely realized. Here, we give a brief overview of the problem, discuss concrete obstacles and the potential for expanded vaccination programs to promote healthy aging.

conclusionThe increasing healthcare burden of infectious diseases expected in aging populations could, to a large extent, be reduced by achieving higher vaccination coverage among older adults. Vaccination can thus contribute to healthy aging, alongside healthy diet and physical exercise. The available evidence indicates that dedicated programs can achieve substantial improvements in vaccination coverage among older adults, but more research is required to assess the generalizability of the results achieved by specific interventions (see Additional file 1).

Indexed as

Demographic changeHealthy agingVaccination programsVaccines

Identifiers

PMID29887922
PMCPMC5972173
OpenAlexW2792164048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.